NCT07504276 Tele-Rehabilitation vs Conventional Rehabilitation for Cognitive Improvement in Stroke Survivors.
| NCT ID | NCT07504276 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 32 participants |
| Start Date | 2026-03-31 |
| Primary Completion | 2026-07-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 32 participants in total. It began in 2026-03-31 with a primary completion date of 2026-07-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to: * Compare tele-rehabilitation and conventional rehabilitation for cognitive improvement after stroke. * Evaluate changes in cognitive function using standardized assessment tools. * Determine whether tele-rehabilitation is as effective as conventional therapy. * Improve evidence-based rehabilitation strategies for stroke survivors.
Eligibility Criteria
Inclusion Criteria: * Adults with age 50-80 * Diagnosed with ischemic or hemorrhagic stroke within subacute to chronic phase. * Moca Score 10-25 score atleast * For tele-rehab must accessible to a digital device. Exclusion Criteria: * History of neurodegenerative disorder e.g Alzheimer's Disease and Parkinson's Disease * Severe Cognitive Impairment * Lack of access to or inability to use a digital device
Contact & Investigator
Imran Amjad, Phd
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT07504276 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, up to 80 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07504276 currently recruiting?
Yes, NCT07504276 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT07504276 trial being conducted?
This trial is being conducted at Islamabad, Pakistan.
Who is sponsoring the NCT07504276 clinical trial?
NCT07504276 is sponsored by Riphah International University. The principal investigator is Imran Amjad, Phd at Riphah International University. The trial plans to enroll 32 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.